(Q39621864)

13 September 2017

title

Raised calcium promotes α-synuclein aggregate formation (English)

1 reference

13 September 2017

1 reference

J. Goodwin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21145971

19 November 2024

S. Nath

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21145971

19 November 2024

Y. Engelborghs

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21145971

19 November 2024

D. L. Pountney

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21145971

19 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21145971

19 November 2024

publication date

9 December 2010

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S1044743110002678?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

https://api.elsevier.com/content/article/PII:S1044743110002678?httpAccept=text/plain

19 November 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Molecular and Cellular Neuroscience

19 November 2024

published in

1 reference

13 September 2017

1 reference

13 September 2017

1 reference

13 September 2017

page(s)

516-526

1 reference

Site-specific interactions of Cu(II) with alpha and beta-synuclein: bridging the molecular gap between metal binding and aggregation

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Parkin-mediated ubiquitin signalling in aggresome formation and autophagy

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

alpha-Synuclein and neuronal cell death

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Different species of alpha-synuclein oligomers induce calcium influx and seeding.

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

The role of parkin in familial and sporadic Parkinson's disease

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Mapping Long-Range Interactions in α-Synuclein using Spin-Label NMR and Ensemble Molecular Dynamics Simulations

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Conformational properties of the SDS-bound state of alpha-synuclein probed by limited proteolysis: unexpected rigidity of the acidic C-terminal tail

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

A stable lipid-induced aggregate of alpha-synuclein

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Conformational properties of alpha-synuclein in its free and lipid-associated states

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

A Drosophila model of Parkinson's disease

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Alpha-synuclein and transgenic mouse models

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Adsorption of alpha-synuclein on lipid bilayers: modulating the structure and stability of protein assemblies

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

alpha-Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH-SY5Y) cells

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Formation and development of Lewy pathology: a critical update

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Controlling the mass action of alpha-synuclein in Parkinson's disease

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Parkinson's disease: from monogenic forms to genetic susceptibility factors

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Proteomics in human Parkinson's disease research

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Calcium(II) selectively induces alpha-synuclein annular oligomers via interaction with the C-terminal domain

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Calcium and neurodegeneration

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Membrane-bound structure and energetics of alpha-synuclein

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Early aggregation steps in alpha-synuclein as measured by FCS and FRET: evidence for a contagious conformational change.

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Ca2+ binding to alpha-synuclein regulates ligand binding and oligomerization

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Curvature dynamics of alpha-synuclein familial Parkinson disease mutants: molecular simulations of the micelle- and bilayer-bound forms

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Annular alpha-synuclein oligomers are potentially toxic agents in alpha-synucleinopathy. Hypothesis

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

In vitro formation of amyloid from alpha-synuclein is dominated by reactions at hydrophobic interfaces.

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Brain-permeable small-molecule inhibitors of Hsp90 prevent alpha-synuclein oligomer formation and rescue alpha-synuclein-induced toxicity

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Multiple system atrophy: an update.

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Intrinsic disorder in proteins associated with neurodegenerative diseases

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K.

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.MCN.2010.12.004

19 November 2024

Identifiers

DOI

1 reference

13 September 2017

1 reference